Ivan Đikić: "I believe leadership means leading by example."

Five minutes with ubiquitin and autophagy expert Ivan Đikić, who will be awarded the 2026 Theodor Bücher medal from FEBS at the 50th FEBS Congress this summer.
Ivan Đikić: "I believe leadership means leading by example."
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks
Ivan Đikić is a distinguished biochemist and molecular biologist and an internationally recognized leader in the fields of ubiquitin signaling and autophagy. He serves as Director of the Institute of Biochemistry II at Goethe University Frankfurt, Germany, and is a Fellow of the Max Planck Institute for Biophysics, where he spearheads cutting-edge research at the interface of biochemistry and medicine. His laboratory has made pioneering contributions to our understanding of cellular quality control pathways, particularly focusing on how ubiquitin and autophagy systems regulate cellular homeostasis and how their dysregulation contributes to cancer, neurodegeneration, and infectious diseases. Recent research from his group has expanded into ER membrane dynamics, and the development of proximity-induced drug modalities, including PROTACs and molecular glues, positioning his team at the forefront of therapeutic innovation. Đikić has long played a leading role in collaborative scientific endeavors. He is the Speaker of the DFG Collaborative Research Centre on Selective Autophagy (since 2016), and the founding force behind several research consortia at Goethe University, including PROXIDRUGS, designed to integrate novel technologies into the development of next-generation drugs targeting protein degradation.

What drew you to your research field?

I have always been driven by curiosity and a strong urge to move beyond my comfort zone. During my postdoctoral work, I studied growth factor signaling pathways that drive cell proliferation. When I started my own lab in Uppsala, Sweden, I became fascinated by a simple but fundamental question: how are these powerful signals switched off? Pursuing this question led us to uncover a pivotal role for ubiquitination in receptor trafficking and degradation, initiating a long-standing line of research that helped establish ubiquitin as a universal signaling system governing the majority of cellular functions.

Tell us about one of your favourite published papers from your lab

There are several papers that are very dear to me, because they opened new insights in unexplored biological questions – for example, how bacteria use the ubiquitin system to attack host cells and how autophagy in host cells engulfs bacteria to be degraded in the lysosome, or how immunity is controlled by linear ubiquitin chains. One paper especially close to my heart (González, A. et al. Nature 2023) revealed how ubiquitination controls ER-phagy, a process that allows cells to remodel and clean their endoplasmic reticulum. We showed that ubiquitin acts as a signal that clusters ER-phagy receptors and reshapes membranes, enabling efficient cellular recycling. This work connected molecular signaling with large-scale organelle remodeling and opened new ways to study cellular quality control.

What’s exciting in your research area right now?

What excites me most is how the cell’s two major degradation systems – the ubiquitin–proteasome system and autophagy – work together to maintain cellular health. These pathways coordinate the removal of damaged proteins and organelles, especially under stress. New imaging, electron microscopy, and computational approaches now allow us to visualize and understand these processes in unprecedented detail.

What’s your lab management style? What do you look for in students and staff?

I enjoy working with knowledgeable, independent, and curious people who are not afraid to challenge ideas. Diversity in expertise, culture, and scientific background is essential for creativity and teamwork. I give my students and postdocs substantial freedom, while expecting responsibility and ownership of their projects. Collaboration within the lab is strongly encouraged, as it accelerates learning and discovery.

What do you consider your most important role as a group and institute leader?

I believe leadership means leading by example. A scientific leader should remain deeply connected to research and not be consumed by administration. Supporting people, solving problems transparently, and maintaining fairness and optimism, even in difficult situations, are essential for building strong and motivated teams.

What are the key ingredients for successful research collaborations?

In my career I had enormous fun working with many collaborators. Successful collaborations are built on shared scientific goals, trust, and open exchange of ideas and data. It is important to respect different expertise and lab cultures and to define expectations and credits clearly from the beginning. I have always enjoyed sharing unpublished ideas at conferences, as this often sparks productive and long-lasting collaborations.

Basic or clinical research? Focused or interdisciplinary? Academia or industry?

I see these as complementary rather than opposing choices. Basic and clinical research, interdisciplinary approaches, and close interactions between academia and industry are all needed. When integrated thoughtfully, they increase the chances of meaningful discoveries and real-world impact.



 
Lab webpage: https://biochem2.com/research-group/molecular-signaling

Two recent/key papers:

González, A. et al. (2023) Ubiquitination regulates ER-phagy and remodeling of the endoplasmic reticulum. Nature 618, 394–401. https://doi.org/10.1038/s41586-023-06089-2

Prieto-Garcia, C. et al. (2024) Pathogenic proteotoxicity of cryptic splicing is alleviated by ubiquitination and ER-phagy. Science 386, 768–776. https://doi.org/10.1126/science.adi5295



More information on the FEBS Theodor Bücher medal and plenary lecture at the 50th FEBS Congress

The Theodor Bücher medal is awarded annually by FEBS for outstanding achievements in Biochemistry and Molecular Biology or related sciences: www.febs.org/other-activities/prizes/febs-medals/

Ivan Đikić will be presented with the medal at the 50th FEBS Congress in Maastricht, the Netherlands on Sunday 5th July 2026, where he will deliver the FEBS Theodor Bücher Lecture on 'Guardians of cellular homeostasis: Ubiquitin–autophagy axis’: https://febscongress.org/


Top image of post: by Gerd Altmann from Pixabay

Join the FEBS Network today

Joining the FEBS Network’s molecular life sciences community enables you to access special content on the site, present your profile, 'follow' contributors, 'comment' on and 'like' content, post your own content, and set up a tailored email digest for updates.